# Auna SA (AUNA) Stock Analysis: Healthcare Giant with a 34% Upside Potential

- Link: https://www.directorstalkinterviews.com/auna-sa-auna-stock-analysis-healthcare-giant-with-a-34-upside-potential/4121259614
- Published: 2026-08-07T10:19:06+01:00
- Author: Madison Wilson

Auna SA (AUNA), a prominent player in the healthcare sector, is capturing investor
interest with its impressive potential upside. As it navigates the medical care 
facilities industry, Auna operates a network of hospitals and clinics across Mexico,
Peru, and Colombia, offering a comprehensive range of services, including prepaid
healthcare and oncology plans. With its headquarters in Luxembourg, Auna SA is positioned
as a dynamic entity in a sector marked by consistent demand and growth.

The company boasts a market capitalization of $385.09 million, reflecting its substantial
footprint in the healthcare industry. Presently trading at $5.20, AUNA’s stock has
remained stable with no significant price change recently, positioned within a 52-
week range of $4.15 to $6.77. This stability, combined with a compelling forward
P/E ratio of 4.62, suggests that the stock is currently undervalued compared to 
its future earnings potential.

A standout feature of Auna SA is its robust revenue growth, clocking in at 13.00%.
This growth trajectory underscores the company’s ability to expand its operations
and capture a larger market share in its operating regions. However, some valuation
metrics, such as the P/E ratio and EV/EBITDA, are not available, which may present
a challenge for investors seeking a comprehensive valuation analysis.

The company’s earnings per share (EPS) stand at 0.27, with a return on equity (ROE)
of 4.59%, indicating efficient utilization of equity capital to generate earnings.
Furthermore, Auna’s free cash flow is a notable $231.47 million, providing the company
with a solid financial foundation to support its growth initiatives and potential
acquisitions.

Despite not offering a dividend yield, Auna’s financial performance and growth potential
are attractive enough to garner positive attention from analysts. The stock enjoys
5 buy ratings and 2 hold ratings, with no sell recommendations, suggesting a strong
consensus of confidence from the analyst community. The target price range of $5.00
to $9.00, with an average target of $6.99, reflects a potential upside of 34.34%,
an enticing prospect for potential investors.

Technical indicators provide further insight into Auna SA’s market position. The
stock’s 50-day moving average is $4.97, closely aligned with its current price, 
while the 200-day moving average stands at $5.10. These figures, alongside a neutral
RSI of 50.00, suggest that AUNA is neither overbought nor oversold in the market,
providing a balanced view for investors.

In summary, Auna SA presents a compelling investment case with significant upside
potential. Its strategic positioning in the healthcare sector, coupled with strong
revenue growth and a supportive analyst outlook, makes it a stock worth watching.
Investors seeking exposure to the healthcare industry might find AUNA’s growth story
and future prospects an attractive addition to their portfolios.

Share on:
